Skip to main content
Log in

PAF - the challenge continues

  • Newsletter Article
  • Published:
Inpharma Weekly

&

The discovery that a rather simple, endogenous phosphoglyceride, now known as platelet-activating factor (PAF), could have potent and diverse biological activities signalled a new era in biochemistry and pharmacology. While the role of PAF in pathological inflammatory processes has been intensively studied by researchers in many countries, the complete definition of the compound’s mode of action has remained elusive to date. However, the secrets of this potent pro-inflammatory phospholipid are now being unravelled. The latest research findings on PAF were presented at the 5th International Congress on Platelet-Activating Factor and Related Lipid Mediators [ Berlin, Germany; September 1995 ].

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schwarz, T. PAF - the challenge continues. Inpharma Wkly. 1011, 19–20 (1995). https://doi.org/10.2165/00128413-199510110-00044

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199510110-00044

Keywords

Navigation